Drug Facts
Composition & Profile
Identifiers & Packaging
HOW SUPPLIED 0.9% Sodium Chloride Injection, USP is supplied in single-dose flexible plastic containers as follows: Product No. NDC No. Strength Fill Sizes Bag Size 1727170102 17271-701-02 0.9% (9 mg/mL) 50 mL 100 mL 1727170103 17271-701-03 0.9% (9 mg/mL) 100 mL 100 mL 1727170105 17271-701-05 0.9% (9 mg/mL) 250 mL 250 mL 1727170106 17271-701-06 0.9% (9 mg/mL) 500 mL 500 mL 1727170107 17271-701-07 0.9% (9 mg/mL) 1,000 mL 1,000 mL Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from freezing. The container closure is not made with natural rubber latex. Non-PVC, Non-DEHP, Sterile. Becton, Dickinson and Company 1 Becton Drive Franklin Lakes, NJ 07417 USA For product inquiry: 1-800-523-0502 Distributed by BD. Manufactured by Fresenius Kabi. Revised: October 2022 BD Logo; PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 50 mL Bag Label free flex ® NDC 17271-701-02 50 mL 0.9% Sodium Chloride Injection, USP For intravenous use. Rx only PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 50 mL Bag Label; PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 50 mL Case Label NDC 17271-701-02 0.9% Sodium Chloride Injection, USP 50 mL x 60 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from freezing. PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 50 mL Case Label; PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 100 mL Bag Label free flex ® NDC 17271-701-03 100 mL 0.9% Sodium Chloride Injection, USP For intravenous use. Rx only PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 100 mL Bag Label; PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 100 mL Case Label NDC 17271-701-03 0.9% Sodium Chloride Injection, USP 100 mL x 50 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from freezing. PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 100 mL Case Label; PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 250 mL Bag Label free flex ® NDC 17271-701-05 250 mL 0.9% Sodium Chloride Injection, USP For intravenous use. Rx only PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 250 mL Bag Label; PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 250 mL Case Label NDC 17271-701-05 0.9% Sodium Chloride Injection, USP 250 mL x 30 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from freezing. PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 250 mL Case Label; PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 500 mL Bag Label free flex ® NDC 17271-701-06 500 mL 0.9% Sodium Chloride Injection, USP For intravenous use. Rx only PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 500 mL Bag Label; PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 500 mL Case Label NDC 17271-701-06 0.9% Sodium Chloride Injection, USP 500 mL x 20 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from freezing. PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 500 mL Case Label; PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 1,000 mL Bag Label free flex ® NDC 17271-701-07 1,000 mL 0.9% Sodium Chloride Injection, USP For intravenous use. Rx only PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 1,000 mL Bag Label; PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 1,000 mL Case Label NDC 17271-701-07 0.9% Sodium Chloride Injection, USP 1,000 mL x 10 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from freezing. PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 1,000 mL Case Label
- HOW SUPPLIED 0.9% Sodium Chloride Injection, USP is supplied in single-dose flexible plastic containers as follows: Product No. NDC No. Strength Fill Sizes Bag Size 1727170102 17271-701-02 0.9% (9 mg/mL) 50 mL 100 mL 1727170103 17271-701-03 0.9% (9 mg/mL) 100 mL 100 mL 1727170105 17271-701-05 0.9% (9 mg/mL) 250 mL 250 mL 1727170106 17271-701-06 0.9% (9 mg/mL) 500 mL 500 mL 1727170107 17271-701-07 0.9% (9 mg/mL) 1,000 mL 1,000 mL Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from freezing. The container closure is not made with natural rubber latex. Non-PVC, Non-DEHP, Sterile. Becton, Dickinson and Company 1 Becton Drive Franklin Lakes, NJ 07417 USA For product inquiry: 1-800-523-0502 Distributed by BD. Manufactured by Fresenius Kabi. Revised: October 2022 BD Logo
- PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 50 mL Bag Label free flex ® NDC 17271-701-02 50 mL 0.9% Sodium Chloride Injection, USP For intravenous use. Rx only PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 50 mL Bag Label
- PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 50 mL Case Label NDC 17271-701-02 0.9% Sodium Chloride Injection, USP 50 mL x 60 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from freezing. PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 50 mL Case Label
- PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 100 mL Bag Label free flex ® NDC 17271-701-03 100 mL 0.9% Sodium Chloride Injection, USP For intravenous use. Rx only PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 100 mL Bag Label
- PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 100 mL Case Label NDC 17271-701-03 0.9% Sodium Chloride Injection, USP 100 mL x 50 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from freezing. PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 100 mL Case Label
- PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 250 mL Bag Label free flex ® NDC 17271-701-05 250 mL 0.9% Sodium Chloride Injection, USP For intravenous use. Rx only PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 250 mL Bag Label
- PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 250 mL Case Label NDC 17271-701-05 0.9% Sodium Chloride Injection, USP 250 mL x 30 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from freezing. PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 250 mL Case Label
- PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 500 mL Bag Label free flex ® NDC 17271-701-06 500 mL 0.9% Sodium Chloride Injection, USP For intravenous use. Rx only PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 500 mL Bag Label
- PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 500 mL Case Label NDC 17271-701-06 0.9% Sodium Chloride Injection, USP 500 mL x 20 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from freezing. PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 500 mL Case Label
- PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 1,000 mL Bag Label free flex ® NDC 17271-701-07 1,000 mL 0.9% Sodium Chloride Injection, USP For intravenous use. Rx only PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 1,000 mL Bag Label
- PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 1,000 mL Case Label NDC 17271-701-07 0.9% Sodium Chloride Injection, USP 1,000 mL x 10 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from freezing. PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Sodium Chloride 1,000 mL Case Label
Overview
0.9% Sodium Chloride Injection, USP solution is sterile and nonpyrogenic. It is a parenteral solution containing sodium chloride in water for injection intended for intravenous administration. For 0.9% Sodium Chloride Injection, USP, each 100 mL contains 900 mg sodium chloride in water for injection. Electrolytes per 1,000 mL: sodium 154 mEq; chloride 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH in the 100 mL and smaller containers is 6.0; for the 250 mL and larger containers, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. The solution contains no bacteriostat, antimicrobial agent or added buffer and is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded. The solution is a parenteral fluid and electrolyte replenisher. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for injection, USP is chemically designated H 2 O. The flexible container is fabricated from a specially formulated non-plasticized, film containing polypropylene and thermoplastic elastomers ( free flex ® bag). The amount of water that can permeate from the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the flexible container can leach out certain of the container's chemical components in very small amounts within the expiration period. The suitability of the container material has been confirmed by tests in animals according to USP biological tests for plastic containers.
Indications & Usage
Intravenous solutions containing sodium chloride are indicated for parenteral replenishment of fluid and sodium chloride as required by the clinical condition of the patient.
Dosage & Administration
The dose is dependent upon the age, weight and clinical condition of the patient. Additives may be incompatible. Consult with pharmacist, if available. When introducing additives, use aseptic technique, mix thoroughly and do not store. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit (see PRECAUTIONS ).
Warnings & Precautions
WARNINGS Sodium Chloride Injection, USP should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency and in clinical states in which there exists edema with sodium retention. The intravenous administration of Sodium Chloride Injection, USP can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema. The risk of dilutive states is inversely proportional to the electrolyte concentration of the injections. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of the injections. In patients with diminished renal function, administration of Sodium Chloride Injection, USP may result in sodium retention.
Contraindications
None known.
Adverse Reactions
Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.
Drug Interactions
Caution must be exercised in the administration of Sodium Chloride Injection, USP to patients receiving corticosteroids or corticotropin. Carcinogenesis, Mutagenesis, Impairment of Fertility Studies have not been performed with Sodium Chloride Injection, USP to evaluate the potential for carcinogenesis, mutagenesis or impairment of fertility. Pregnancy: Teratogenic Effects Animal reproduction studies have not been conducted with Sodium Chloride Injection, USP. It is also not known whether Sodium Chloride Injection, USP can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Sodium Chloride Injection, USP should be given to a pregnant woman only if clearly needed. Labor and Delivery Studies have not been conducted to evaluate the effects of Sodium Chloride Injection, USP on labor and delivery. Caution should be exercised when administering this drug during labor and delivery. Nursing Mothers It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Sodium Chloride Injection, USP is administered to a nursing mother. Pediatric Use The use of Sodium Chloride Injection, USP in pediatric patients is based on clinical practice. Plasma electrolyte concentrations should be closely monitored in the pediatric population as this population may have impaired ability to regulate fluids and electrolytes. Geriatric Use Clinical studies of Sodium Chloride Injection, USP did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or drug therapy. This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function. Do not administer unless solution is clear and container is undamaged. Discard unused portion.
Similar Drugs
Related medications based on brand, generic name, substance, active ingredients.